06.10.2015 • News

Clariant to Buy Part of Vivimed Portfolio

Swiss specialty chemicals producer Clariant said it intends to acquire a part of Vivimed Labs’ personal care portfolio.

Clariant said the acquisition of the Indian company will enable its wholly owned subsidiary Clariant India to strengthen its personal care portfolio within the Industrial & Consumer Specialties (ICS) business unit and offer a wider product portfolio within the sun, skin, hair and oral care range as well as anti-microbial preservatives.

“The personal care industry in India offers us immense potential, supported by the growing middle-class consumer population and the rising disposable income,” said Deepak Parikh, Clariant’s region president for India, Middle East and Africa.

Santosh Varalwar, CEO of Vivimed Labs, said the deal with Clariant will “significantly improve” his company’s financial flexibility and position it for further growth across its specialty chemicals and pharmaceuticals businesses.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.